Clinical Outcomes of the Transplantation of Stem Cells from Various Human Tissue Sources in the Management of Liver Cirrhosis: A Systematic Review and Meta-Analysis

被引:27
作者
Qi, Xingshun [1 ]
Guo, Xiaozhong [1 ]
Su, Chunping [2 ]
机构
[1] Gen Hosp Shenyang Mil Area, Dept Gastroenterol, Shenyang, Peoples R China
[2] Lib Fourth Mil Med Univ, Xian, Peoples R China
关键词
Child-Pugh; liver cirrhosis; liver function; MELD; meta analysis; stem cell; treatment; BONE-MARROW-CELLS; SHORT-TERM; AUTOLOGOUS INFUSION; HEPATIC-ARTERY; IMPROVEMENT; MODALITY; FIBROSIS; VARICES; TRIALS;
D O I
10.2174/1574888X09666141112114011
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Aims: A systematic review and meta-analysis were performed to explore the clinical outcome of the transplantation of stem cells from various human tissue sources in cirrhotic patients. Methods: The relevant papers were searched via PubMed, EMBASE, and Cochrane Library databases. Changes in liver function before and after stem cell therapy were evaluated (self-control data). Difference in liver function and incidence of procedure-related complications, hepatocellular carcinoma (HCC), and death between patients undergoing stem cell therapy and conventional treatment were evaluated (case-control data). Results: Of 786 papers initially identified, 31 were included. The sources of stem cell included bone marrow (n=26), umbilical cord (n=3), peripheral blood (n=1), and human fetal liver (n=1). No severe procedure-related complications were reported. According to the meta-analyses of self-control data, model for end-stage liver diseases (MELD) score was significantly reduced at the 3rd-4th and 6th months after stem cell therapy, but this reduction was not statistically significant at the 1st-2nd or 12th postoperative months. Child-Pugh score was also reduced after stem cell therapy, but the reduction was not statistically significant at all follow-up time points. According to the meta-analyses of case-control data, MELD and Child-Pugh scores were not significantly different between treatment and control groups at all follow-up time points. The incidence of HCC was not significantly different between treatment and control groups (odds ratio [OR] to=0.41, P=0.53). The mortality was not significantly different between the two groups (OR=0.48, P=0.20). Conclusion: Stem cell therapy could improve the liver function without any severe procedure-related complications. However, compared with conventional treatment, the benefit of stem cell therapy appeared to be not significant in improving the liver function and survival.
引用
收藏
页码:166 / 180
页数:15
相关论文
共 58 条
  • [1] Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
    Akiyama, Kentaro
    Chen, Chider
    Wang, DanDan
    Xu, Xingtian
    Qu, Cunye
    Yamaza, Takayoshi
    Cai, Tao
    Chen, WanJun
    Sun, Lingyun
    Shi, Songtao
    [J]. CELL STEM CELL, 2012, 10 (05) : 544 - 555
  • [2] Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study
    Amin, Mona A.
    Sabry, Dina
    Rashed, Laila A.
    Aref, Wael M.
    el-Ghobary, Mohamed Ahmed
    Farhan, Marwa Salah
    Fouad, Hany Ahmed
    Youssef, Youssef Abdel-Aziz
    [J]. CLINICAL TRANSPLANTATION, 2013, 27 (04) : 607 - 612
  • [3] Improved survival after variceal bleeding in patients with cirrhosis over the past two decades
    Carbonell, N
    Pauwels, A
    Serfaty, L
    Fourdan, O
    Lévy, VG
    Poupon, R
    [J]. HEPATOLOGY, 2004, 40 (03) : 652 - 659
  • [4] Chen Hai-ou, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P537, DOI 10.3760/cma.j.issn.1007-3418.2010.07.016
  • [5] Autologous bone marrow cells in the treatment of cirrhosis of the liver
    Chernykh, E. R.
    Starostina, N. M.
    Paltsev, A. I.
    Leplina, O. Yu.
    Shevela, E. Ya.
    Shipunov, M. V.
    Selihova, Yu. B.
    Kulagin, A. D.
    Lisukov, I. A.
    Nikonov, S. D.
    Ostanin, A. A.
    Kozlov, V. A.
    [J]. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2007, 144 (04) : 640 - 645
  • [6] Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice
    Cho, Kyung-Ah
    Lim, Goh-Woon
    Joo, Sun-Young
    Woo, So-Youn
    Seoh, Ju-Young
    Cho, Su Jin
    Han, Ho-Seong
    Ryu, Kyung-Ha
    [J]. LIVER INTERNATIONAL, 2011, 31 (07) : 932 - 939
  • [7] El-Ansary M., 2010, Stem Cell., V1, P22
  • [8] Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis
    El-Ansary, Mervat
    Abdel-Aziz, Iman
    Mogawer, Sherif
    Abdel-Hamid, Samah
    Hammam, Olfat
    Teaema, Salwa
    Wahdan, Marwa
    [J]. STEM CELL REVIEWS AND REPORTS, 2012, 8 (03) : 972 - 981
  • [9] Fu N, 2011, WORLD CHIN J DIG, V19, P2376
  • [10] Fu N, 2010, WORLD CHIN J DIG, V18, P2274